219 related articles for article (PubMed ID: 16414973)
1. Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma.
Gelber AC; Pillemer SR; Baum BJ; Wigley FM; Hummers LK; Morris S; Rosen A; Casciola-Rosen L
Ann Rheum Dis; 2006 Aug; 65(8):1028-32. PubMed ID: 16414973
[TBL] [Abstract][Full Text] [Related]
2. Anticentromere antibody-positive primary Sjögren's syndrome: Epitope analysis of a subset of anticentromere antibody-positive patients.
Tanaka N; Muro Y; Suzuki Y; Nishiyama S; Takada K; Sekiguchi M; Hashimoto N; Ohmura K; Shimoyama K; Saito I; Kawano M; Akiyama M
Mod Rheumatol; 2017 Jan; 27(1):115-121. PubMed ID: 27161330
[TBL] [Abstract][Full Text] [Related]
3. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
[TBL] [Abstract][Full Text] [Related]
4. Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies.
Akbarali Y; Matousek-Ronck J; Hunt L; Staudt L; Reichlin M; Guthridge JM; James JA
J Autoimmun; 2006 Dec; 27(4):272-80. PubMed ID: 17210244
[TBL] [Abstract][Full Text] [Related]
5. Antigen-driven selection of antibodies against SSA, SSB and the centromere 'complex', including a novel antigen, MIS12 complex, in human salivary glands.
Takeshita M; Suzuki K; Kaneda Y; Yamane H; Ikeura K; Sato H; Kato S; Tsunoda K; Arase H; Takeuchi T
Ann Rheum Dis; 2020 Jan; 79(1):150-158. PubMed ID: 31611218
[TBL] [Abstract][Full Text] [Related]
6. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
[TBL] [Abstract][Full Text] [Related]
7. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
8. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
9. Anti-CENP-H antibodies in patients with Sjogren's syndrome.
Hsu TC; Chang CH; Lin MC; Liu ST; Yen TJ; Tsay GJ
Rheumatol Int; 2006 Feb; 26(4):298-303. PubMed ID: 15700116
[TBL] [Abstract][Full Text] [Related]
10. Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss.
Schachna L; Wigley FM; Morris S; Gelber AC; Rosen A; Casciola-Rosen L
Arthritis Rheum; 2002 Jul; 46(7):1873-84. PubMed ID: 12124872
[TBL] [Abstract][Full Text] [Related]
11. Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis.
Hudson M; Mahler M; Pope J; You D; Tatibouet S; Steele R; Baron M; ; Fritzler M
J Rheumatol; 2012 Apr; 39(4):787-94. PubMed ID: 22467948
[TBL] [Abstract][Full Text] [Related]
12. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and immunological features of primary Sjögren's syndrome patients with positive anti-centromere protein B antibody].
Meng YH; Chen YF; Zhou PR
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1088-1096. PubMed ID: 38101794
[TBL] [Abstract][Full Text] [Related]
14. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
15. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
[TBL] [Abstract][Full Text] [Related]
16. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
17. Clinical and serological evaluation of a novel CENP-A peptide based ELISA.
Mahler M; Maes L; Blockmans D; Westhovens R; Bossuyt X; Riemekasten G; Schneider S; Hiepe F; Swart A; Gürtler I; Egerer K; Fooke M; Fritzler MJ
Arthritis Res Ther; 2010; 12(3):R99. PubMed ID: 20487535
[TBL] [Abstract][Full Text] [Related]
18. Anti-centromere autoantibody in a patient evolving from a lupus/Sjögren's overlap to the CREST variant of scleroderma.
Ford AL; Kurien BT; Harley JB; Scofield RH
J Rheumatol; 1998 Jul; 25(7):1419-24. PubMed ID: 9676778
[TBL] [Abstract][Full Text] [Related]
19. Sjögren's syndrome with anticentromere antibodies.
Caramaschi P; Biasi D; Carletto A; Manzo T; Randon M; Zeminian S; Bambara LM
Rev Rhum Engl Ed; 1997 Dec; 64(12):785-8. PubMed ID: 9476266
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of autoantibodies to the pericentromeric heterochromatin protein 1a protein.
Coppo P; Henry-Dessailly I; Rochette J; Lok C; Buendia B; Lassoued K
Eur J Intern Med; 2013 Dec; 24(8):868-71. PubMed ID: 24184038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]